Close
  Indian J Med Microbiol
 

Figure 3: (A) Representative images of immunohistochemistry staining of desmin in gall bladder tumours (no diaminobenzidine, DAB stain) and adjacent non-tumour showing positive DAB stain, counterstain used was haematoxylin. (B) Histogram showing percentage of immunohistochemical staining patterns of desmin in gall bladder tumours and adjacent non-tumours. (C) Western blotting showing expression of desmin in five representative samples of gall bladder tumour (T1-T5) and their adjacent non-tumour (N1-N5). (D) Histogram showing the densitometric quantitation of desmin expression in gall bladder tumours and non-tumours from the western blotting (n=5 in both groups).

Figure 3: (<b>A</b>) Representative images of immunohistochemistry staining of desmin in gall bladder tumours (no diaminobenzidine, DAB stain) and adjacent non-tumour showing positive DAB stain, counterstain used was haematoxylin. (<b>B</b>) Histogram showing percentage of immunohistochemical staining patterns of desmin in gall bladder tumours and adjacent non-tumours. (<b>C</b>) Western blotting showing expression of desmin in five representative samples of gall bladder tumour (T1-T5) and their adjacent non-tumour (N1-N5). (<b>D</b>) Histogram showing the densitometric quantitation of desmin expression in gall bladder tumours and non-tumours from the western blotting (n=5 in both groups).